ConductScience.org, home

Gene · 55894

DEFB103B: defensin beta 103B

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. DEFB103B: defensin beta 103B. Genes, record 55894. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55894

On this page

Gene

Symbol
DEFB103B
HGNC
Name
defensin beta 103B
HGNC
NCBI Gene ID
55894
NCBI Gene
HGNC ID
HGNC:31702
HGNC
Ensembl
ENSG00000177243
NCBI Gene
Aliases
BD-3, DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P81534Beta-defensin 103671Ensembl, GeneID, HGNC

Source UniProt

Patents153

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-195350P81534Espacenet
EP 4650780 A22025-11-195562P81534Espacenet
JP 2025169942 A2025-11-14942P81534Espacenet
JP 2025169942 A2025-11-14943P81534Espacenet
JP 2025147176 A2025-10-064128P81534Espacenet
JP 2025147176 A2025-10-064129P81534Espacenet
US 12409247 B22025-09-0952P81534Espacenet
US 12409247 B22025-09-0972P81534Espacenet
JP 2025529142 A2025-09-046136P81534Espacenet
JP 2025529142 A2025-09-046137P81534Espacenet

1 to 10 of 153

See all 153 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,004

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleDEFB103B papersNewest fiscal year
P30AI036219Rustbelt Center for AIDS Research (Case/UHC-Pitt CFAR)122025
P30EY007551Center Core Grant for Vision Research92025
R37DE022550Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis82025
P30DK054759Precision Medicine Center for Cystic Fibrosis62025
P30CA177558University of Kentucky Markey Cancer Center – Cancer Center Support Grant52025
P30ES005605Environmental Health Sciences Research Center52025
T32CA165990Interdisciplinary Research Training in Cancer Biology52025
T90DE023520University of Iowa Institutional Training Program in Oral Health Research52025
P30CA043703Case Comprehensive Cancer Center Support Grant42025
ZIAAI000904Staphylococcal pathogenesis42025

1 to 10 of 1,004Source NIH's project files

See all 1,004 nih grants

Papers2,388

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
[Value of LTB4 and hBD-3 expression in gingival crevicular fluid combined with random forest model for predicting the risk of peri-implantitis during the maintenance period of implant restoration patients].
Shanghai Kou Qiang Yi Xue202642736248PubTator, text miningPubMed
Differential Epidermal and Dermal Expression of Human β-Defensin-3 in Paired Lesional and Non-Lesional Psoriatic Skin.Dermatology202642704748PubTator, text miningPubMed
Umbrella Sampling Simulations of Human β Defensin Type 1 and 3 Crossing Model Bacterial Membranes.J Phys Chem B202642691412PubTator, text miningPubMed
Human beta defensins 3 and 6 serve as diagnostic tools for identifying sepsis and pneumonia.Front Immunol202642661652PubTator, text miningPubMed
Design of a novel epitope-based tetravalent subunit vaccine against dengue virus: An immunoinformatic approach.PLoS One202642520062PubTator, text miningPubMed
APOA1, DEFB103A_DEFB103B and DSG3 Are Novel Circulating Biomarkers of Psoriasis.Int J Mol Sci202642450078PubTator, text miningPubMed
Prognostic Significance of Tumour Budding and Tumour-infiltrating Lymphocytes in Gallbladder Carcinoma.J West Afr Coll Surg202642445769PubTator, text miningPubMed
Computational design and validation of a multi-epitope subunit vaccine against the neglected parasite blastocystis sp.In Silico Pharmacol202642438779PubTator, text miningPubMed
In silico design and evaluation of a multi-epitope vaccine targeting eyach virus for the prevention of tick-borne encephalitis in humans.Sci Rep202642380441PubTator, text miningPubMed
Designing a multi-epitope vaccine against yellow fever virus using immunoinformatics approaches.Open Med (Wars)202642317441PubTator, text miningPubMed

1 to 10 of 2,388

See all 2,388 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/55894

GET https://conductscience.org/api/genes/v1/55894/patents?page=2